Home/ Supplements/ Melatonin/ Melatonin 3 mg Sustained Release

Melatonin 3 mg Sustained Release

product on market Tablet or Pill KAL Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 100% of ingredients have research evidence
A Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · grounded in 1 source · methodology

Melatonin is supported by strong evidence for managing sleep onset and circadian rhythm disruptions. Riboflavin and Vitamin B6 contribute to energy metabolism and neurological function, though their role in sleep support is less established. Overall, the evidence coverage for this specific combination is limited.

AI-generated summary based on research evidence. Not medical advice.

Label

Product Label

Label for Melatonin 3 mg Sustained Release
Open Full PDF View on NIH DSLD →
Details

Label Data

1 Tablet(s)
Serving Size
60
Servings
Other Combinations
Product Type
100%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

2.1 mg (162% DV)
1.6× RDA — within safe limits 13 studies (A:0, B:1)
4.1 mg (241% DV)
3.2× RDA — above typical dose (UL: 100 mg) 114 studies (A:3, B:35)
3 mg
Market median: 3.0mg (984 products) 240 studies (A:2, B:109)

Other Ingredients

Cellulose Magnesium Stearate Silica Stearic Acid
Claims

Label Claims — Verification

Unverified Nutrient
Unverified All Other
Unverified Structure/Function
Info

Product Information

Directions for Use

1 Daily

Directions: Take 1 tablet daily. Use only as directed.

Warnings & Precautions

Warning: Do not use if safety seal is broken or missing. Do not take prior to or while operating machinery or a vehicle or engaged in an activity where you need to stay alert.

Consult a licensed health care practitioner before using this product, especially if you are pregnant or nursing, a young adult or individual with autoimmune conditions, diabetes or other endocrine disorders, depressive disorders, illness or using medications.

Keep out of reach of children. Consult a licensed health care practitioner before using this product, especially if you are pregnant or nursing, a young adult or individual with autoimmune conditions, diabetes or other endocrine disorders, depressive disorders, illness or using medications. This product is for adults and should not be used by children or teenagers.

Formulation Notes

Sustained Release Healthy Sleep Cycle Support

Vegan

Gluten free

Discussion: When you are ready to doze off, cozy up with melatonin, vitamin B6 and riboflavin and have sweet dreams of rested mornings.

Additional Information

Vegan

PCR Bottle

Store in a cool, dry place.

Metadata

Product Details

UPC / SKU0 21245 75006 2
DSLD Entry Date2025-02-23
Product TypeOther Combinations
FormTablet or Pill
BrandKAL
DSLD ID322924
Data Updated2026-04-11
Research

Research Evidence

291
Research Sources
55
Avg Quality
129
Meta Analysis
93
Systematic Review
51
Rct
11
Clinical Trial
2
Other
2
Regulatory Source
1
Openfda Safety
A Interventions for preventing delirium in hospitalised non-ICU patients
Meta Analysis The Cochrane database of systematic reviews 2016 PubMed DOI
A Melatonin for preoperative and postoperative anxiety in adults
Meta Analysis The Cochrane database of systematic reviews 2020 PubMed DOI
A Effect of melatonin on quality of life and symptoms in patients with cancer: a systematic review and meta-analysis of randomised controlled trials
Meta Analysis BMJ open 2022 PubMed DOI
B Pharmacological interventions for prevention of weight gain in people with schizophrenia
Meta Analysis The Cochrane database of systematic reviews 2022 PubMed DOI
B Melatonin for pre- and postoperative anxiety in adults
Meta Analysis The Cochrane database of systematic reviews 2015 PubMed DOI
B Prevention of depression in adults with long-term physical conditions
Meta Analysis The Cochrane database of systematic reviews 2021 PubMed DOI
B Comparative effects of pharmacological interventions for the acute and long-term management of insomnia disorder in adults: a systematic review and network meta-analysis
Systematic Review Lancet (London, England) 2022 PubMed DOI
B Does melatonin administration reduce the incidence of postoperative delirium in adults? Systematic review and meta-analysis
Meta Analysis BMJ open 2023 PubMed DOI
B Second-generation antidepressants for preventing seasonal affective disorder in adults
Meta Analysis The Cochrane database of systematic reviews 2015 PubMed DOI
B Interventions for preventing type 2 diabetes in adults with mental disorders in low- and middle-income countries
Meta Analysis The Cochrane database of systematic reviews 2021 PubMed DOI
View all evidence for Melatonin →
Compare

Similar Products

View all Melatonin products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.